Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-10

Inflammatory Bowel Diseases

Volumn 17, Issue 10, 2011, Pages 2038-2046

  Pils, Marina C ^a   Bleich, André ^b   Prinz, Immo ^b   Fasnacht, Nicolas ^f   Bollati Fogolin, Mariela ^c   Schippers, Angela ^a,d   Rozell, Björn ^e   Müller, Werner ^a,g  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f EPFL   (Switzerland)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

commensal flora; conditional knockout; DSS colitis; interleukin 10; T cells

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; SODIUM SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE DELETION; GENE INACTIVATION; HISTOPATHOLOGY; IMMUNE RESPONSE; INTESTINE FLORA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; BLOTTING, WESTERN; COLITIS; CYTOKINES; DENDRITIC CELLS; DEXTRAN SULFATE; DISEASE SUSCEPTIBILITY; FEMALE; GASTROINTESTINAL TRACT; IMMUNITY, INNATE; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MALE; METAGENOME; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 80052755511     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21587     Document Type: Article

References (44)

1. Berg DJ, Kühn R, Rajewsky K, et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 1995; 96: 2339-2347.
2. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009; 361: 2033-2045.
3. Kühn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75: 263-274.
4. Bleich A, Mähler M, Most C, et al. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome. 2004; 15: 865-871.
5. Mähler M, Leiter EH,. Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. Inflamm Bowel Dis. 2002; 8: 347-355.
6. Roers A, Siewe L, Strittmatter E, et al. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J Exp Med. 2004; 200: 1289-1297.
7. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998; 66: 5224-5231.
8. Stehr M, Greweling MC, Tischer S, et al. Charles River altered Schaedler flora (CRASF) remained stable for four years in a mouse colony housed in individually ventilated cages. Lab Anim. 2009; 43: 362-370.
9. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990; 98: 694-702.
10. Egger B, Bajaj-Elliott M, MacDonald TT, et al. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion. 2000; 62: 240-248.
11. Tomoyose M, Mitsuyama K, Ishida H, et al. Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis. Scand J Gastroenterol. 1998; 33: 435-440.
12. Ni J, Chen SF, Hollander D,. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut. 1996; 39: 234-241.
13. Kitajima S, Takuma S, Morimoto M,. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim. 1999; 48: 137-143.
14. Dieleman LA, Ridwan BU, Tennyson GS, et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology. 1994; 107: 1643-1652.
15. Axelsson LG, Landström E, Goldschmidt TJ, et al. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res. 1996; 45: 181-191.
16. Kim TW, Seo JN, Suh YH, et al. Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis. World J Gastroenterol. 2006; 12: 302-305.
17. Rath HC, Schultz M, Freitag R, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001; 69: 2277-2285.
18. Kitajima S, Morimoto M, Sagara E, et al. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp Anim. 2001; 50: 387-395.
19. Okada Y, Tsuzuki Y, Miyazaki J, et al. Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut. 2006; 55: 681-688.
20. Osman N, Adawi D, Molin G, et al. Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol. 2006; 6: 31.
21. Frick JS, Fink K, Kahl F, et al. Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics. Infect Immun. 2007; 75: 3490-3497.
22. Ukena SN, Singh A, Dringenberg U, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One. 2007; 2: e1308.
23. Östman S, Rask C, Wold AE, et al. Impaired regulatory T cell function in germ-free mice. Eur J Immunol. 2006; 36: 2336-2346.
24. Strauch UG, Obermeier F, Grunwald N, et al. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut. 2005; 54: 1546-1552.
25. Souza DG, Vieira AT, Soares AC, et al. The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol. 2004; 173: 4137-4146.
26. Kühn R, Rajewsky K, Müller W,. Generation and analysis of interleukin-4 deficient mice. Science. 1991; 254: 707-710.
27. Magram J, Connaughton SE, Warrier RR, et al. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity. 1996; 4: 471-481.
28. Siewe L, Bollati-Fogolin M, Wickenhauser C, et al. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur J Immunol. 2006; 36: 3248-3255.
29. Lee PP, Fitzpatrick DR, Beard C, et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity. 2001; 15: 763-774.
30. Rickert RC, Roes J, Rajewsky K,. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 1997; 25: 1317-1318.
31. Clausen BE, Burkhardt C, Reith W, et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999; 8: 265-277.
32. Rajewsky K, Gu H, Kühn R, et al. Conditional gene targeting. J Clin Invest. 1996; 98: 600-603.
33. Pils MC, Pisano F, Fasnacht N, et al. Monocytes/macrophages and/or neutrophils are the target of Interleukin-10 in the LPS endotoxemia model. Eur J Immunol. 2010; 40: 443-448.
34. Araki A, Kanai T, Ishikura T, et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol. 2005; 40: 16-23.
35. Hans W, Schölmerich J, Gross V, et al. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol. 2000; 12: 267-273.
36. Kitajima S, Takuma S, Morimoto M,. Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights. Exp Anim. 2000; 49: 9-15.
37. Bygrave AE, Rose KL, Cortes-Hernandez J, et al. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2004; 2: E243.
38. Iwata M, Hirakiyama A, Eshima Y, et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity. 2004; 21: 527-538.
39. Wynn TA, Morawetz R, Scharton-Kersten T, et al. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J Immunol. 1997; 159: 5014-5023.
40. O'Garra A, Vieira P,. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol. 2007; 7: 425-428.
41. Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med. 1995; 182: 1281-1290.
42. Liu Z, Geboes K, Heremans H, et al. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis. Eur J Immunol. 2001; 31: 1550-1560.
43. Mannon PJ, Fuss IJ, Mayer L, et al. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med. 2004; 351: 2069-2079.
44. Hansen JJ, Holt L, Sartor RB,. Gene expression patterns in experimental colitis in IL-10-deficient mice. Inflamm Bowel Dis. 2009; 15: 890-899.